![](https://bioluminescence.com/wp-content/uploads/2023/05/trees-2.jpg)
Investing in the future of medicine.
![](https://bioluminescence.com/wp-content/uploads/2023/05/glow.jpg)
Bioluminescence Ventures is a US biotechnology venture capital firm headquartered in San Francisco.
Our team invests in companies with transformational platform technologies that are developing first-in-class or best-in-class therapeutics programs.
- Breakthrough Biology
- Drug Discovery Platforms
- Genetic Medicines Platforms
- Computational Biology Platforms
![](https://bioluminescence.com/wp-content/uploads/2023/05/lanterns-2.jpg)
Purpose
Bioluminescence Ventures was conceptualized to finance breakthrough platforms and support mission-driven leaders to develop first-in-class or best-in-class therapies for patients with major unmet medical needs.
We believe that this is especially critical at a time when we are simultaneously experiencing both a golden age of biomedical innovation and the most difficult financing environment in over a decade.
Bioluminescence is light emitted by living beings. It is a metaphor for our guiding light: patient impact. We see this light radiating from our mission-driven founders and CEOs. We aim to support them with our time, energy, interdisciplinary expertise, capital, and commitment over the long run.
We aim to make their light shine brighter.
![BLV founder Kouki Harasaki participates in a panel at BIO2023](https://bioluminescence.com/wp-content/uploads/2023/10/Panel-1.jpg)
People
Passionate about biomedical innovations.